MedTrace Logo

Comparison of Fluoxetine Versus Citalopram Therapy to Control Postmenopausal Vasomotor Syndrome

NCT05346445 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 91

Last updated 2022-07-26

No results posted yet for this study

Summary

This study determined the efficacy of non-hormonal therapy with citalopram compared to fluoxetine, for the treatment of menopausal symptoms in Mexican women with vasomotor syndrome (VMS) and urogenital syndrome.

Conditions

Interventions

DRUG

Fluoxetine 20 MG

Participants received non-hormonal treatment with fluoxetine.

DRUG

Citalopram 20mg

Participants received non-hormonal treatment with citalopram.

Sponsors & Collaborators

  • Universidad Nacional Autonoma de Mexico

    collaborator OTHER

  • National Polytechnic Institute, Mexico

    collaborator OTHER

  • Hospital Regional 1o de Octubre

    lead OTHER

Principal Investigators

  • Juan M Ocampo-Godinez, M.D., Ph.D. · Tissue Bioengineering Laboratory, National Autonomous University of Mexico [UNAM]

  • Patricia Loranca-Moreno, M.D., M.Sc. · Peri-postmenopause and bone metabolism clinic. Regional Hospital October 1st ISSSTE

  • Alan Rios-Espinosa, M.D. · Peri-postmenopause and bone metabolism clinic. Regional Hospital October 1st ISSSTE

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-20
Primary Completion
2021-11-20
Completion
2021-12-20

Countries

  • Mexico

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05346445 on ClinicalTrials.gov